8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
CooperCompanies reports 1% Q3 revenue growth and retains CooperSurgical
Filed with the SEC on · Summarized by InvestorsBot
CooperCompanies reported third-quarter fiscal 2026 revenue of $1.066 billion, up 1% year over year, with non-GAAP diluted EPS of $1.15 and free cash flow of $273 million; GAAP EPS was $2.24, including a $307.2 million U.K. tax benefit. The company completed its strategic review and will retain CooperSurgical, increased its share repurchase authorization from $2 billion to $3 billion, and guided to fiscal 2026 revenue of $4.229 billion to $4.252 billion and non-GAAP EPS of $4.51 to $4.55.